Aryldialkylphosphatase - Wikipedia
Aryldialkylphosphatase (EC 3.1.8.1, also known as phosphotriesterase, organophosphate hydrolase, parathion hydrolase, ...
NIOSHTIC-2 Search Results - Full View
györgy found 5 records - Provincial Hospitals Library Catalogue - Nova Scotia Health Authority
公共衛生學院 - 研究成果 - 臺北醫學大
Identification of carboxylesterase, butyrylcholinesterase, acetylcholinesterase, paraoxonase, and albumin pseudoesterase in...
School of Public Health - Research output - Taipei Medical University
Pham, T. T. M., Duong, T. V., Nguyen, L. T. K., Vu, M-T., Pham, K. M., Nguyen, M. H., Luong, T. C., Do, B. N., Le, L. T. H., Dang, N. H., Nguyen, T. T. P., Le, H. P., Tran, C. Q., Nguyen, K. T., Hu, C-J., Chan, C-C., Hsu, H-C. & Bai, C-H., 2023, In: Nutrients.. Research output: Contribution to journal › Article › peer-review ...
NOVA Medical School|Faculdade de Ciências Médicas (NMS|FCM) - Research output
- Universidade NOVA de Lisboa
Kazdin, A. E., Wu, C. S., Hwang, I., Puac-Polanco, V., Sampson, N. A., Al-Hamzawi, A., Alonso, J., Andrade, L. H., Benjet, C., Caldas-De-Almeida, J. M., De Girolamo, G., De Jonge, P., Florescu, S., Gureje, O., Haro, J. M., Harris, M. G., Karam, E. G., Karam, G., Kovess-Masfety, V., Lee, S., & 19 othersMcGrath, J. J., Navarro-Mateu, F., Nishi, D., Oladeji, B. D., Posada-Villa, J., Stein, D. J., Üstün, T. B., Vigo, D. V., Zarkov, Z., Zaslavsky, A. M., Kessler, R. C., Atwoli, L., Altwaijri, Y., Borges, G., Bromet, E. J., Bunting, B., Kiejna, A., Scott, K. M. & Ten Have, M., Mar 2023, In: Psychological Medicine. 53, 4, p. 1583 - 1591. Research output: Contribution to journal › Article › peer-review ...
Kannapolis Research - Works - Citation Index - NCSU Libraries
Biology - Research output - Montclair State University
Springer, N. M., Anderson, S. N., Andorf, C. M., Ahern, K. R., Bai, F., Barad, O., Barbazuk, W. B., Bass, H. W., Baruch, K., Ben-Zvi, G., Buckler, E. S., Bukowski, R., Campbell, M. S., Cannon, E. K. S., Chomet, P., Kelly Dawe, R., Davenport, R., Dooner, H. K., Du, L. H., Du, C., & 34 othersEasterling, K. A., Gault, C., Guan, J. C., Hunter, C. T., Jander, G., Jiao, Y., Koch, K. E., Kol, G., Köllner, T. G., Kudo, T., Li, Q., Lu, F., Mayfield-Jones, D., Mei, W., McCarty, D. R., Noshay, J. M., Portwood, J. L., Ronen, G., Settles, A. M., Shem-Tov, D., Shi, J., Soifer, I., Stein, J. C., Stitzer, M. C., Suzuki, M., Vera, D. L., Vollbrecht, E., Vrebalov, J. T., Ware, D., Wei, S., Wimalanathan, K., Woodhouse, M. R., Xiong, W. & Brutnell, T. P., 1 Sep 2018, In: Nature Genetics. 50, 9. Research output: Contribution to journal › Article › peer-review ...
Paraoxonase 1 interactions with HDL, antioxidants and macrophages regulate atherogenesis - A protective role for HDL...
Kinetics of HDL cholesterol and paraoxonase activity in moderate alcohol consumers | TNO Publications
Proatherogenic or antiatherogenic high density lipoprotein type in acute coronary syndrome and healthy male person<...
The Combined Effect of Paraoxonase Promoter and Coding Region Polymorphisms on the Risk of Arterial Ischemic Stroke among Young...
Category:Pages with citations lacking titles - wikidoc
Synthetic Allergens for Studying Type-1 Hypersensitivity
Candidate gene polymorphisms related to lipid metabolism in Asian Indians living in Durban, South Africa. - Centre for Tropical...
Polymers | Free Full-Text | Carrier Variety Used in Immobilization of His6-OPH Extends Its Application Areas
Medical Science Monitor | A Case-Control Study on the Oxidative Status in Women with Polycystic Ovary Syndrome Treated with...
BACKGROUND:Polycystic ovary syndrome (PCOS) is associated with infertility or subfertility due to impaired ovulation. Clomiphene citrate is a first-line treatment option for the induction of ovulation in women with PCOS. The study aimed to compare markers of oxidative stress or the total oxidative status (TOS), total antioxidant status (TAS), and levels of paraoxonase-1 (PON-1) before and after day 21 of the menstrual cycle in women with PCOS treated with clomiphene citrate to induce ovulation.
MATERIAL AND METHODS:The study included 75 women who were divided into a control group (n=25) that included healthy untreated women, untreated women with PCOS (n=24) who had spontaneous ovulation, and women with PCOS who were treated with clomiphene citrate for subfertility or infertility (n=26) (the PCOS-CC group). The study group was treated for five days with clomiphene citrate (50 mg/day). Peripheral venous blood was sampled on day 3 and day 21 of the menstrual cycle from women in all three groups, and TAS,